<DOC>
	<DOC>NCT02524496</DOC>
	<brief_summary>Due to the lack of other drugs to treat gastroparesis Janssen and FDA approved the compassionate use of cisapride to treat patients who had no other effective therapy. For this observational study, 3 patients who had already been prescribed cisapride by outside physicians, were followed to determine the effectiveness of cisapride on their gastric emtpying.</brief_summary>
	<brief_title>Limited Access Protocol for the Use of Oral Cisapride</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<mesh_term>Cisapride</mesh_term>
	<criteria>Clinical diagnosis of gastroparesis. No diagnosis of gastroparesis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>